You have selected a link to a third-party Web site. This link is provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of such third-party Web site. EMD Serono is not responsible for and does not make any representations regarding the accuracy of materials on such third-party site.
You have selected a link to a third-party Web site. This link is provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of such third-party Web site. EMD Serono is not responsible for and does not make any representations regarding the accuracy of materials on such third-party site.
You have selected a link to a third-party Web site. This link is provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of such third-party Web site. EMD Serono is not responsible for and does not make any representations regarding the accuracy of materials on such third-party site.
You have selected a link to a third-party Web site. This link is provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of such third-party Web site. EMD Serono is not responsible for and does not make any representations regarding the accuracy of materials on such third-party site.
You have selected a link to a third-party Web site. This link is provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of such third-party Web site. EMD Serono is not responsible for and does not make any representations regarding the accuracy of materials on such third-party site.
You have selected a link to a third-party Web site. This link is provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of such third-party Web site. EMD Serono is not responsible for and does not make any representations regarding the accuracy of materials on such third-party site.
Gonal-f® Cares about helping inform patients
about fertility.
Gonal-f® Cares about directing patients to
helpful information.
Gonal-f® Cares about breaking down patient financial barriers.
Gonal-f® Cares about
keeping you updated and
informed on reproductive
health.
Gonal-f® Cares about
providing resources
to help patients.
Indication:
For women, Gonal-f® (follitropin alfa for injection), Gonal-f® RFF (follitropin alfa injection) and Gonal-f® RFF Pen (follitropin alfa injection) are indicated for 1) the induction of ovulation and pregnancy in the anovulatory infertile patient in whom the cause of infertility is functional and not due to primary ovarian failure and 2) for the development of multiple follicles in the ovulatory patient participating in an ART program.
Gonal-f® is also indicated for the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure.
Important Safety Information:
These products should only be prescribed by physicians specializing in fertility or reproductive health. Use of Gonal-f® or Gonal-f® RFF by women can result in multiple births.
Gonal-f® and Gonal-f® RFF are potent gonadotropins capable of causing mild to severe adverse reactions, including Ovarian Hyperstimulation Syndrome (OHSS) in women with or without pulmonary complications. Gonal-f® and Gonal-f® RFF are contraindicated in women and men who exhibit prior hypersensitivity to recombinant FSH preparations or one of their excipients, high levels of FSH indicating primary gonadal failure, uncontrolled thyroid or adrenal dysfunction, sex hormone dependent tumors of the reproductive tract and accessory organs, and an organic intracranial lesion such as a pituitary tumor. Additionally, Gonal-f® and Gonal-f® RFF should not be given to women with abnormal bleeding, presence or enlargement of an ovarian cyst of undetermined origin, or who are pregnant or nursing.
The most common side effects reported in women using Gonal-f® and Gonal-f® RFF include headache, abdominal pain, enlarged abdomen, ovarian cysts, nausea, and upper respiratory infections. Men using Gonal-f® have commonly reported acne, breast pain and growth, fatigue. Injection site reactions have been reported.
Please see accompanying prescribing information below for full disclosure.
RFF: Revised Formulation Female
©2011 EMD Serono, Inc. and its affiliates.
This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.
This site contains information that is intended for US residents only. Canadian residents should consult the EMD Serono Canada Inc. Web site at www.emdserono.ca for information on products and services approved in Canada.
